Skip to main content
Innovotech Inc. logo

Innovotech Inc. — Investor Relations & Filings

Ticker · IOT ISIN · CA45772U1049 TSXV Professional, scientific and technical activities
Open in API
Filings indexed 330 across all filing types
Latest filing 2021-03-01 Regulatory Filings
Country CA Canada
Listing TSXV IOT

About Innovotech Inc.

https://innovotech.ca/

Innovotech Inc. is a specialist in antimicrobial and biofilm solutions, recognized as a pioneer in biofilm product development and contract research. The company focuses on providing innovative and practical solutions to medical, agricultural, and industrial problems caused by microbial biofilms. Key offerings include specialized assay kits used globally for growing microbial biofilms in research applications. Through Innovotech Labs, the company provides comprehensive, accredited (GMP and ISO) contract testing services, including analytical, microbiological, and antimicrobial testing. These services target the pharmaceutical, biotechnology, medical device, and nutraceutical industries, aiming to ensure regulatory compliance and product optimization.

Recent filings

Filing Released Lang Actions
Report of exempt distribution excluding schedule 1 of Form 5.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'Form 45-106F1 Report of Exempt Distribution' and contains detailed information about securities distribution, including issuer information, distribution dates, purchaser details, and exemptions relied upon. It is a regulatory filing form used in Canada to report exempt distributions of securities. The content is a formal regulatory report rather than a financial statement, earnings release, or management discussion. It does not contain financial performance data or audit information but is a compliance report related to securities distribution. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory compliance documents that do not fit other specific categories.
2021-03-01 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the final approval by the TSX Venture Exchange of a convertible loan acquisition by Innovotech Inc. It details the terms of the debenture acquisition, related party transaction exemptions, and background information about the companies involved. There are no financial statements, quarterly or annual results, or detailed financial analysis present. The document is an announcement of a financing transaction and related regulatory approval rather than a full financial report or earnings release. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length (6205 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2021-02-23 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a news release announcing the approval of a transaction by the TSX Venture Exchange for Innovotech Inc. to acquire a 60% interest in Nou Life Sciences Inc. It discusses the terms of the acquisition, the technology involved, and includes forward-looking statements and disclaimers. There are no financial statements, detailed financial performance data, or comprehensive report content. The document is an announcement of a capital transaction and financing activity rather than a full report or detailed financial disclosure. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is short and it is not a report publication announcement or regulatory filing. Confidence is high due to clear transaction details and exchange approval mention.
2021-01-19 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a news release announcing the termination of an acquisition agreement between Innovotech Inc. and Lonsdale Capital Corporation. It discusses the withdrawal of an offer and provides some background on the company's business and outlook. There are no financial statements, detailed financial data, or regulatory form references. The document is short (3070 characters) and serves as an announcement of a capital transaction update rather than a full report or filing. Therefore, it fits best under Capital/Financing Update (CAP).
2021-01-18 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing Innovotech's acquisition of shares in other listed health sector companies. It details the issuance of shares as consideration, the regulatory context including exemptions under Multilateral Instrument 61-101, and the strategic rationale behind the acquisition. There are no financial statements, quarterly or annual results, or detailed financial analysis present. The document is not a full financial report, earnings release, or management discussion. It is an update on a capital transaction involving share issuance and acquisition of shares, which fits the category of Capital/Financing Update (CAP). The document length is about 4809 characters, which is sufficient for a detailed announcement but not a full report. Therefore, the best classification is CAP with high confidence.
2021-01-05 English
News release - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is a detailed report on Innovotech's financial results for the third quarter and nine months ended September 30, 2020. It includes specific financial figures such as revenues, net income, working capital, and corporate developments including collaboration agreements, acquisitions, and financing activities. The presence of comprehensive financial data and analysis for a period shorter than a full fiscal year (quarter and nine months) indicates this is an Interim / Quarterly Report. The document is about 5980 characters, which is sufficient to contain substantive financial data, not just an announcement or summary. Therefore, it fits the definition of an Interim / Quarterly Report (IR). 9M 2020
2020-11-13 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.